NIA-AA Symposium: Enabling Precision Medicine for Alzheimer's Disease Through Open Science

Pre-recorded event: Available on-demand starting Monday, July 27, 2020
Live session: Friday, July 31, 2020 at 8:30 a.m. Central Standard Time

Overview

This symposium will feature an array of translational research programs that integrate computational and experimental approaches to:

  1. Discover novel, disease-relevant targets and biomarkers.
  2. Develop next-generation animal models and target enabling tools.
  3. Support the development of new candidate therapeutics for a diverse portfolio of targets.
  4. Advance data-driven drug repositioning and combination therapy development.

The featured programs will include:

Agenda

View the agenda.

Target Audience

Academic, biotech and pharmaceutical industry researchers with interest in target and biomarker discovery, preclinical and clinical drug development; computational biologists; data scientists; and open science advocates.

Scheduling Note

Pre-recorded materials will become available on-demand beginning Monday, July 27. A live session will be held on Friday, July 31. All pre-recorded content will be available for 30 days after the conference.

Become an ISTAART Member

Go beyond the conference — network and collaborate year-round with a global community of leaders who are working to advance Alzheimer’s and dementia research.


JOIN NOW

Join the Conversation #AAIC20

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs